Site Members can sign up for company wide alerts
Lawsuit Overview
March 25, 2022 - An amended complaint was filed. October 25, 2021 - An investor, in shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by BioMarin Pharmaceutical Inc. in connection with certain allegedly false and misleading statements made between J...
You must register (for free) or login to view the entire case.